Search results
FDA Warns Of Potential For Cyanide Poisoning After Apricot Seed Company Declines Recall
Tasting Table via Yahoo News· 3 hours agoWhen it comes to raw apricot kernels, however, some experts have claimed that eating more than three...
Nearly 1.9 million cases of water impacted by FDA recall
KSNT Topeka via Yahoo News· 1 day agoTOPEKA (KSNT) – The Food and Drug Administration (FDA) says a bottled water producer is recalling...
FDA withdraws Helsinn’s accelerated approval for cancer drug after company’s request
Endpoints News· 5 days agoThe FDA on Friday withdrew an accelerated approval for Helsinn’s bile duct cancer drug, two years...
What to know about the blood test to detect colon cancer recommended by an FDA panel
ABC News via Yahoo News· 1 day agoA blood test to screen for colorectal cancer is one step closer to receiving approval from the U.S....
FDA upgrades safety alert for Hologic's breast cancer marking implant, after 71 reported injuries
FierceBiotech· 1 day agoThe FDA is upgrading its safety warnings related to complications from Hologic’s implantable marker...
With Duchenne decision ahead, FDA’s Marks pushes for speedy gene therapy approvals
BioPharma Dive via Yahoo Finance· 1 day agoBut the head of the FDA’s CBER office didn’t tip where the agency stands on potentially broadening...
FDA advisers weigh benefits of weekly insulin for people with diabetes
CNN.com· 1 day agoNow, the maker of a once-weekly insulin injection is seeking approval from the US Food and Drug...
FDA grants IND clearance for Abdera’s Phase I cancer therapy trial
Clinical Trials Arena via Yahoo Finance· 1 day agoThe US Food and Drug Administration (FDA) has granted clearance for Abdera Therapeutics'...
FDA Roundup: May 24, 2024
The Woonsocket Call· 1 day agoOn Thursday, the FDA announced that Medline Industries, LP, a firm marketing and distributing plastic syringes made in China within the U.S., initiated a recall to stop using ...
FDA panel backs Guardant’s blood test for colon cancer
MedTech Dive via Yahoo Finance· 1 day agoWilliam Blair analyst Andrew Brackmann said the FDA appears on its way to approving Shield. Still,...